# A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis

> **NCT01122914** · PHASE1 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 1 (actual)

## Conditions studied

- Anakinra
- Kineret
- Atopic Dermatitis
- Eczema
- Allergic Disease

## Interventions

- **DRUG:** Anakinra

## Key facts

- **NCT ID:** NCT01122914
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04-14
- **Primary completion:** 2015-04-07
- **Final completion:** 2015-04-07
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01122914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01122914, "A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01122914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*